Common stock

Starboard Delivers Open Letter to Box Stockholders

Retrieved on: 
Tuesday, July 20, 2021
Finance, Money, Starboard Value, Corporate finance, Common stock, Financial economics

NEW YORK, July 20, 2021 /PRNewswire/ -- Starboard Value LP (together with its affiliates, "Starboard" or "we"), one of the largest stockholders of Box, Inc. ("Box" or the "Company") (NYSE: BOX), with an ownership stake of approximately 8.4% of the Company's outstanding shares, today announced that it has delivered an open letter to Box stockholders and has filed definitive proxy materials with the Securities and Exchange Commission in connection with Starboard's nomination of a slate of three highly-qualified director nominees for election to the Box Board of Directors at the upcoming 2021 Annual Meeting of Stockholders.

Key Points: 
  • NEW YORK, July 20, 2021 /PRNewswire/ -- Starboard Value LP (together with its affiliates, "Starboard" or "we"), one of the largest stockholders of Box, Inc. ("Box" or the "Company") (NYSE: BOX), with an ownership stake of approximately 8.4% of the Company's outstanding shares, today announced that it has delivered an open letter to Box stockholders and has filed definitive proxy materials with the Securities and Exchange Commission in connection with Starboard's nomination of a slate of three highly-qualified director nominees for election to the Box Board of Directors at the upcoming 2021 Annual Meeting of Stockholders.
  • Starboard also announced that it has launched www.ShareholdersforBox.com to provide additional information to its fellow stockholders.
  • The full text of Starboard's open letter to Box stockholders follows and can also be viewed at the following link:
    A LETTER TO THE STOCKHOLDERS OF BOX, INC.
    We are writing to you today about your investment in Box, Inc. ("Box" or the "Company").
  • Starboard Value LP (together with its affiliates, "Starboard" or "we") currently owns approximately 8.4% of the outstanding common stock of Box, making us one of the Company's largest stockholders.

LSB Industries, Inc. Announces Transaction to Exchange Outstanding Series E-1 and F-1 Preferred Stock for Common Stock; Plans to Pay 0.3:1 Special Common Stock Dividend to Existing Common Stockholders

Retrieved on: 
Tuesday, July 20, 2021
Commercial Building & Real Estate, Agriculture, Construction & Property, Natural Resources, Engineering, Chemicals, Plastics, Other Construction & Property, Manufacturing, Financial markets, Financial economics, Finance, Corporate finance, Equity securities, Stock market, Dividends, Preferred stock, Special dividend, Stock, Common stock, Ex-dividend date, LSB Industries, Inc., Eldridge, LSB INDUSTRIES, INC., ELDRIDGE

In connection with the transaction, existing unaffiliated LSB common stockholders will receive a special dividend in the form of 0.30 shares of LSB common stock for every share owned as of the record date.

Key Points: 
  • In connection with the transaction, existing unaffiliated LSB common stockholders will receive a special dividend in the form of 0.30 shares of LSB common stock for every share owned as of the record date.
  • Mark Behrman, LSBs President and CEO, stated, The Special Committee, the Board of Directors and management believe that the exchange of our outstanding Series E-1 and F-1 preferred stock for LSB common stock relieves the Company and our common stockholders from the expensive, compounding burden of the payment-in-kind dividend this preferred stock carries.
  • Over the last several years we have evaluated options to reduce or eliminate our preferred stock.
  • However, during that period, the nitrogen chemical market pricing environment has not been helpful as selling prices had been at multi-year lows.

Transaction in own shares

Retrieved on: 
Monday, July 19, 2021
Equity securities, Corporate finance, Financial economics, Common stock, Finance, Money

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • Arix intends to retain the purchased shares in treasury.
  • Following settlement of the above purchase, Arix will have 131,044,800 ordinary shares of 0.001 pence each in issue (excluding 4,564,853 ordinary shares of 0.001p each held in treasury).
  • In accordance with Article 5(1)(b) of Regulation (EU) No.

RENNOVA HEALTH, INC. COMPLETES REVERSE STOCK SPLIT

Financial markets, Corporate finance, Finance, Financial economics, Stock market, Equity securities, Reverse stock split, Warrant, Preferred stock, Stock split, Stock, Common stock

As a result of the reverse stock split, every 1,000 shares of the Companys common stock issued and outstanding on the Effective Time were consolidated into one issued and outstanding share, except to the extent that the reverse stock split resulted in any of the Companys stockholders owning a fractional share, which fractional share will be in that case paid in cash.

Key Points: 
  • As a result of the reverse stock split, every 1,000 shares of the Companys common stock issued and outstanding on the Effective Time were consolidated into one issued and outstanding share, except to the extent that the reverse stock split resulted in any of the Companys stockholders owning a fractional share, which fractional share will be in that case paid in cash.
  • Based on the number of shares outstanding on July 16, the reverse stock split reduced the number of shares of the Companys common stock outstanding from approximately 10 billion pre-reverse split shares to approximately 10 million post-reverse split.
  • All outstanding preferred shares, stock options, warrants, and equity incentive plans immediately prior to the reverse stock split generally were appropriately adjusted by dividing the number of shares of common stock into which the preferred shares, stock options, warrants and equity incentive plans were exercisable or convertible by 1,000 and multiplying the exercise or conversion price by 1,000, as a result of the reverse stock split.
  • Stockholders owning shares via a broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, subject to brokers particular processes, and will not be required to take any action in connection with the reverse stock split.

Spectra7 Announces Share Consolidation

Retrieved on: 
Monday, July 19, 2021
Financial economics, Corporate finance, Finance, Stock market, Equity securities, Mergers and acquisitions, Corporate law, Consolidation, Share, Common stock, Issued shares

SAN JOSE, Calif., July 19, 2021 /PRNewswire/ --(TSXV:SEV) (OTCQB:SPVNF) Spectra7 Microsystems Inc. ("Spectra7" or the "Company"), announces that board of directors of the Company has approved a consolidation of the Company's issued and outstanding common shares on the basis one new common share for every 50 existing common shares (the "Consolidation").

Key Points: 
  • SAN JOSE, Calif., July 19, 2021 /PRNewswire/ --(TSXV:SEV) (OTCQB:SPVNF) Spectra7 Microsystems Inc. ("Spectra7" or the "Company"), announces that board of directors of the Company has approved a consolidation of the Company's issued and outstanding common shares on the basis one new common share for every 50 existing common shares (the "Consolidation").
  • As a result of the Consolidation, the 1,056,538,784 common shares issued and outstanding prior to the Consolidation will be reduced to approximately 21,130,775 common shares.
  • Shareholder approval of the Consolidation was obtained at the Company's annual and special meeting of shareholders held on June 18, 2021.
  • The Company expects the Consolidation to be effective and the trading of the common shares of the Company reflecting the Consolidation to commence on or about August 6, 2021.

DGAP-News: MorphoSys Concludes a US$ 100 Million Capital Increase to Implement the Purchase of 1,337,552 shares by Royalty Pharma

Retrieved on: 
Friday, July 16, 2021
Equity securities, Financial economics, Finance, Corporate finance, Stock market, MorphoSys, Corporate law, Royalty payment, Royalty Pharma, Share capital, Stock, Common stock

The new ordinary shares represent 3.9% of the registered share capital of MorphoSys following the capital increase.

Key Points: 
  • The new ordinary shares represent 3.9% of the registered share capital of MorphoSys following the capital increase.
  • "We're pleased that Royalty Pharma is taking an equity position in MorphoSys as part of the long-term strategic finance partnership the two companies entered into this year," said Sung Lee, Chief Financial Officer of MorphoSys.
  • The new MorphoSys shares will be listed on the Frankfurt Stock Exchange.
  • Royalty Pharma has agreed, subject to limited exceptions, not to sell or otherwise transfer any of the new ordinary shares for a period of twelve months.

Transaction in own shares

Retrieved on: 
Friday, July 16, 2021
Equity securities, Corporate finance, Financial economics, Common stock, Finance, Money

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • Arix intends to retain the purchased shares in treasury.
  • Following settlement of the above purchase, Arix will have 131,065,800 ordinary shares of 0.001 pence each in issue (excluding 4,543,853 ordinary shares of 0.001p each held in treasury).
  • In accordance with Article 5(1)(b) of Regulation (EU) No.

OceanTech Acquisitions I Corp. Announces Separate Trading of its Class A Common Stock and Warrants to Commence on July 19, 2021

Retrieved on: 
Friday, July 16, 2021
Finance, Powerboating, Sports, Professional services, Yachting, Financial markets, Corporate finance, Equity securities, Financial economics, Finance, Stock market, Options, Warrant, Stock, Common stock, Dilutive security, Stock option expensing

Each Unit consists of one share of Class A common stock and one Public Warrant, with each Public Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share.

Key Points: 
  • Each Unit consists of one share of Class A common stock and one Public Warrant, with each Public Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share.
  • Shares of Class A Common Stock and the Public Warrants will trade on the Nasdaq Capital Market under the symbols OTEC and OTECW, respectively.
  • Holders of Units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Companys transfer agent, in order to separate the Units into shares of Class A Common Stock and Public Warrants.
  • The Company is sponsored by OceanTech Acquisitions I Sponsors LLC, an affiliate of investor and entrepreneur Joseph Adir.

Clarivate Declares Dividend on Mandatory Convertible Preferred Stock

Retrieved on: 
Friday, July 16, 2021
Financial markets, Finance, Financial economics, Corporate finance, Equity securities, Preferred stock, Dividend, Common stock, Clarivate

As permitted by the Statement of Rights governing its 5.25% Series A Mandatory Convertible Preferred Shares, such dividend will be payable solely by delivery of ordinary shares (other than cash in lieu of any fractional ordinary share).

Key Points: 
  • As permitted by the Statement of Rights governing its 5.25% Series A Mandatory Convertible Preferred Shares, such dividend will be payable solely by delivery of ordinary shares (other than cash in lieu of any fractional ordinary share).
  • This communication contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.
  • Additional risks and uncertainties not known to us or that we currently deem immaterial may also impair our business operations.
  • Clarivate is a global leader in providing solutions to accelerate the lifecycle of innovation.

Clarivate Declares Dividend on Mandatory Convertible Preferred Stock

Retrieved on: 
Friday, July 16, 2021
Financial markets, Finance, Financial economics, Corporate finance, Equity securities, Preferred stock, Dividend, Common stock, Clarivate

As permitted by the Statement of Rights governing its 5.25% Series A Mandatory Convertible Preferred Shares, such dividend will be payable solely by delivery of ordinary shares (other than cash in lieu of any fractional ordinary share).

Key Points: 
  • As permitted by the Statement of Rights governing its 5.25% Series A Mandatory Convertible Preferred Shares, such dividend will be payable solely by delivery of ordinary shares (other than cash in lieu of any fractional ordinary share).
  • This communication contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.
  • Additional risks and uncertainties not known to us or that we currently deem immaterial may also impair our business operations.
  • Clarivate is a global leader in providing solutions to accelerate the lifecycle of innovation.